JP2008528534A5 - - Google Patents

Download PDF

Info

Publication number
JP2008528534A5
JP2008528534A5 JP2007552587A JP2007552587A JP2008528534A5 JP 2008528534 A5 JP2008528534 A5 JP 2008528534A5 JP 2007552587 A JP2007552587 A JP 2007552587A JP 2007552587 A JP2007552587 A JP 2007552587A JP 2008528534 A5 JP2008528534 A5 JP 2008528534A5
Authority
JP
Japan
Prior art keywords
opioid
salt
dosage form
less
controlled release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007552587A
Other languages
English (en)
Japanese (ja)
Other versions
JP5704789B2 (ja
JP2008528534A (ja
Filing date
Publication date
Priority claimed from GBGB0501638.1A external-priority patent/GB0501638D0/en
Priority claimed from PCT/GB2005/050014 external-priority patent/WO2005079760A1/en
Application filed filed Critical
Priority claimed from PCT/EP2006/000727 external-priority patent/WO2006079550A2/en
Publication of JP2008528534A publication Critical patent/JP2008528534A/ja
Publication of JP2008528534A5 publication Critical patent/JP2008528534A5/ja
Application granted granted Critical
Publication of JP5704789B2 publication Critical patent/JP5704789B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2007552587A 2005-01-28 2006-01-27 耐アルコール性剤形 Expired - Lifetime JP5704789B2 (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
GB0501638.1 2005-01-28
GBGB0501638.1A GB0501638D0 (en) 2005-01-28 2005-01-28 Particulates
PCT/GB2005/050014 WO2005079760A1 (en) 2004-02-12 2005-02-11 Particulates
GBPCT/GB2005/050014 2005-02-11
US67050605P 2005-04-12 2005-04-12
US60/670,506 2005-04-12
US73033905P 2005-10-26 2005-10-26
US60/730,339 2005-10-26
PCT/EP2006/000727 WO2006079550A2 (en) 2005-01-28 2006-01-27 Alcohol resistant dosage forms

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012284017A Division JP2013100306A (ja) 2005-01-28 2012-12-27 耐アルコール性剤形

Publications (3)

Publication Number Publication Date
JP2008528534A JP2008528534A (ja) 2008-07-31
JP2008528534A5 true JP2008528534A5 (enExample) 2008-10-23
JP5704789B2 JP5704789B2 (ja) 2015-04-22

Family

ID=34259727

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007552587A Expired - Lifetime JP5704789B2 (ja) 2005-01-28 2006-01-27 耐アルコール性剤形
JP2012284017A Pending JP2013100306A (ja) 2005-01-28 2012-12-27 耐アルコール性剤形

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012284017A Pending JP2013100306A (ja) 2005-01-28 2012-12-27 耐アルコール性剤形

Country Status (11)

Country Link
EP (3) EP3228308A1 (enExample)
JP (2) JP5704789B2 (enExample)
CN (1) CN101132772B (enExample)
AP (1) AP2274A (enExample)
EA (1) EA015615B1 (enExample)
GB (1) GB0501638D0 (enExample)
IL (1) IL184858A (enExample)
MA (1) MA29368B1 (enExample)
NZ (2) NZ560669A (enExample)
TN (1) TNSN07293A1 (enExample)
ZA (1) ZA200705913B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090317355A1 (en) * 2006-01-21 2009-12-24 Abbott Gmbh & Co. Kg, Abuse resistant melt extruded formulation having reduced alcohol interaction
US20070212414A1 (en) * 2006-03-08 2007-09-13 Penwest Pharmaceuticals Co. Ethanol-resistant sustained release formulations
US9757343B2 (en) * 2008-09-24 2017-09-12 Evonik Röhm Gmbh PH-dependent controlled release pharmaceutical opioid composition with resistance against the influence of ethanol
WO2010105673A1 (en) * 2009-03-18 2010-09-23 Evonik Röhm Gmbh Controlled release pharmaceutical composition with resistance against the influence of ethanol employing a coating comprising a polymer mixture and excipients
US9730899B2 (en) * 2009-03-18 2017-08-15 Evonik Roehm Gmbh Controlled release pharmaceutical composition with resistance against the influence of ethanol employing a coating comprising neutral vinyl polymers and excipients
GB0909680D0 (en) * 2009-06-05 2009-07-22 Euro Celtique Sa Dosage form
KR20130030260A (ko) * 2010-05-10 2013-03-26 유로-셀티큐 에스.에이. 히드로모르폰 및 날록손을 포함하는 제약 조성물
NZ603173A (en) * 2010-05-10 2014-10-31 Euro Celtique Sa Manufacturing of active-free granules and tablets comprising the same
WO2011141490A1 (en) * 2010-05-10 2011-11-17 Euro-Celtique S.A. Combination of active loaded granules with additional actives
GB201020895D0 (en) * 2010-12-09 2011-01-26 Euro Celtique Sa Dosage form
WO2012166474A1 (en) * 2011-06-01 2012-12-06 Fmc Corporation Controlled release solid dose forms
BR112014009033A2 (pt) * 2011-10-18 2017-10-17 Purdue Pharma Lp formulações de polímero acrílico
DK2838512T3 (en) * 2012-04-18 2018-11-19 Gruenenthal Gmbh MANIPULATED AND DOSAGE DUMPED PHARMACEUTICAL DOSAGE FORM
CA2795324C (en) * 2012-11-09 2015-07-14 Purdue Pharma Pharmaceutical compositions comprising hydromorphone and naloxone
CN105120846B (zh) * 2013-02-05 2019-10-18 普渡制药公司 抗篡改的药物制剂
US11806433B2 (en) 2017-11-01 2023-11-07 Edgemont Pharmaceuticals, LLC Trust Alcohol-resistant oral pharmaceutical compositions of lorazepam

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8626098D0 (en) * 1986-10-31 1986-12-03 Euro Celtique Sa Controlled release hydromorphone composition
US5656295A (en) 1991-11-27 1997-08-12 Euro-Celtique, S.A. Controlled release oxycodone compositions
US5266331A (en) 1991-11-27 1993-11-30 Euroceltique, S.A. Controlled release oxycodone compositions
US5968551A (en) 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
NZ260408A (en) * 1993-05-10 1996-05-28 Euro Celtique Sa Controlled release preparation comprising tramadol
US5965161A (en) * 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
DE19710008A1 (de) * 1997-03-12 1998-09-17 Basf Ag Feste, mindestens zweiphasige Zubereitungsformen eines Opioid-Analgeticums mit verzögerter Freisetzung
WO1999001111A1 (en) * 1997-07-02 1999-01-14 Euro-Celtique, S.A. Stabilized sustained release tramadol formulations
DE19901085C2 (de) * 1999-01-14 2003-12-18 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit einer selbstklebenden Matrix, enthaltend organische Säure-Additionssalze von Alkaloiden des Morphin- bzw. Morphinantyps
US20030118641A1 (en) 2000-07-27 2003-06-26 Roxane Laboratories, Inc. Abuse-resistant sustained-release opioid formulation
AU776666B2 (en) 2000-02-08 2004-09-16 Euro-Celtique S.A. Tamper-resistant oral opioid agonist formulations
GB0026137D0 (en) * 2000-10-25 2000-12-13 Euro Celtique Sa Transdermal dosage form
WO2003004009A1 (en) * 2001-07-02 2003-01-16 Geneva Pharmaceuticals, Inc. Pharmaceutical composition
KR20040060917A (ko) * 2001-08-06 2004-07-06 유로-셀티크 소시에떼 아노뉨 오피오이드 남용을 방지하기 위한 조성물 및 방법
CA2455420A1 (en) * 2001-08-06 2003-02-20 Euro-Celtique, S.A. Compositions and methods to prevent abuse of opioids
CA2478515C (en) * 2002-04-05 2010-09-28 Purdue Pharma Pharmaceutical preparation containing oxycodone and naloxone
JP4694207B2 (ja) 2002-07-05 2011-06-08 コルジウム ファーマシューティカル， インコーポレイテッド オピオイドおよび他の薬物に関する乱用抑止性の薬学的組成物
CA2499994C (en) * 2002-09-23 2012-07-10 Verion, Inc. Abuse-resistant pharmaceutical compositions
ATE482695T1 (de) * 2002-12-13 2010-10-15 Durect Corp Orale darreichungsform mit flüssigen hochviskosen trägersystemen
EP1585501A4 (en) * 2003-01-23 2007-04-25 Amorepacific Corp PREPARATIONS OF DELAYED RELEASE AND METHOD OF MANUFACTURING THEREOF
TWI357815B (en) * 2003-06-27 2012-02-11 Euro Celtique Sa Multiparticulates
TWI350762B (en) * 2004-02-12 2011-10-21 Euro Celtique Sa Particulates

Similar Documents

Publication Publication Date Title
CA2913368C (en) Abuse deterrent immediate release formulation
JP2006524249A5 (enExample)
AU2008286914B2 (en) Abuse resistant drugs, method of use and method of making
HRP20100289T1 (hr) Proizvodi otporni na miješanje za opioidnu primjenu
US20160175454A1 (en) Tamper-Resistant Pharmaceutical Dosage Forms and Process for Making Same
JP4997109B2 (ja) 用量比例的な定常状態ｃａｖｅおよび定常状態ａｕｃ、ならびに、用量比例よりも小さい単回投与ｃｍａｘを有するオピオイド投薬形態物
US12208094B2 (en) Extended release, abuse deterrent dosage forms
JP2006524261A5 (enExample)
HRP20120641T1 (hr) Oralni farmaceutski oblici doziranja otporni na neovlašteno korištenje koji sadrže opioidni analgetik
CA2640339A1 (en) Tamper resistant opioid dosage forms
WO2013158810A1 (en) Immediate release pharmaceutical compositions with abuse deterrent properties
CA2938699A1 (en) Abuse-resistant drug formulations with built-in overdose protection
US20250017917A1 (en) Pharmaceutical dosage forms
WO2009015734A2 (en) Dosage form comprising immediate release naproxen and sustained release opioid analgesic
EP3079676A1 (en) Crush-resistant solid oral dosage form
WO2020159901A1 (en) Abrasion-resistant opioid formulations which resist abuse and include a sequestered opioid antagonist
KR20190028656A (ko) 내마모성 오피오이드 제형
US20200222329A1 (en) Abuse deterrent oral solid dosage form
TH86206A (th) ผลิตภัณฑ์ทางเภสัชกรรม
US20180185352A1 (en) Abuse deterrent pharmaceutical compositions